Veeva SystemsBSP:V2EE34 93 OCF Margin % is 127.65% as of Apr. 2026, which is 235% above its 10-year median of 38.10. GuruFocus rates BSP:V2EE34 with a GF Score™ of 93/100 and a GF Value™ of R$48.02 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 669 Healthcare Providers & Services companies, Veeva Systems ranks better than 98.21% on this metric.
The historical rank and industry rank for Veeva Systems's OCF Margin % or its related term are showing as below:
BSP:V2EE34'
s OCF Margin % Range Over the Past 10 Years
Min: 26.16 Med: 38.1 Max: 44.29
Current: 48.77
During the past 13 years, the highest OCF Margin % of Veeva Systems was 44.29%. The lowest was 26.16%. And the median was 38.10%.
BSP:V2EE34's OCF Margin % is ranked better than 98.21% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 8.29
vs BSP:V2EE34: 48.77
Veeva Systems OCF Margin % Related Terms
Veeva Systems OCF Margin % Historical Data
* Premium members only.
The historical data trend for Veeva Systems's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:V2EE34 vs BTSG, TEM, HQY: OCF Margin % Comparison
For the Health Information Services subindustry, Veeva Systems's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Veeva Systems's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (BSP:V2EE34) has a OCF Margin % of 127.65% as of Apr. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Veeva Systems and its competitors. This is 235% above median its historical median of 38.10. Over the past decade, Veeva Systems' OCF Margin % has ranged from 26.16 to 44.29. According to the industry distribution chart, Veeva Systems ranks #12 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 1.8%.
Is Veeva Systems' OCF Margin % too high?
Veeva Systems' current OCF Margin % of 127.65% is 235% above median its 10-year median of 38.10. Over the past 10 years, this metric has ranged from a low of 26.16 to a high of 44.29. The Healthcare Providers & Services industry median OCF Margin % is 8.29. Veeva Systems' value of 127.65% is 1439.8% above this industry median. Based on the distribution chart, Veeva Systems ranks #12 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Veeva Systems has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' OCF Margin % compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #12 out of 669 companies for OCF Margin %. This places Veeva Systems in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 8.29. Veeva Systems' value of 127.65% is 1439.8% above this benchmark. Historically, Veeva Systems' own OCF Margin % has ranged from 26.16 to 44.29 over the past decade. While the company's 10-year median is 38.10 vs. the industry median of 8.29, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.29, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current OCF Margin % of 127.65% is 1439.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current OCF Margin % is 127.65%, which is 235% above median its own 10-year median of 38.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (BSP:V2EE34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$48.02, compared to a current price of R$27.18 — trading 43.4% below its estimated fair value. The current OCF Margin % is 127.65%, which is 235% above median its 10-year median of 38.10 and 1439.8% above the Healthcare Providers & Services industry median of 8.29. Veeva Systems' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Veeva Systems (BSP:V2EE34), the current OCF Margin % is 127.65% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (BSP:V2EE34) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of R$27.18 is trading 43.4% below its estimated GF Value™ of R$48.02.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for BSP:V2EE34:
OCF Margin %: 127.65% (235% above median its 10-year median of 38.10)
GF Value™: R$48.02 vs. price of R$27.18 (43.4% below fair value)
Industry Position: 1439.8% above the Healthcare Providers & Services median (#12 of 669)
No single metric tells the full story. See the BSP:V2EE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
93GF Score
Get the complete analysis for BSP:V2EE34
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:V2EE34 has been successfully added to your 
